Phasing in human-relevant science: Why the UK’s roadmap matters – and how to make it work (original) (raw)

Authors

Thomas Hartung Center for Alternatives to Animal Testing, Bloomberg School of Public Health and Whiting School of Engineering, Doerenkamp-Zbinden-Chair for Evidence-based Toxicology, Johns Hopkins University, Baltimore, MD, USA; CAAT-Europe, University of Konstanz, Konstanz, Germany

DOI:

References

Hartung, T. (2021). Pyrogen testing revisited on occasion of the 25th anniversary of the whole blood test. ALTEX 38, 3-19. doi:10.14573/altex.2101051

Hartung, T. (2025) The turning point: April 2025 marks historic shift in US animal testing policy. ALTEX 42, 536-537. doi:10.14573/altex.2504301

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).

How to Cite

“Phasing in human-relevant science: Why the UK’s roadmap matters – and how to make it work” (2026) ALTEX - Alternatives to Animal Experimentation, 43(1), pp. 176–177. doi:10.14573/altex.2511111.

Lucy Meigs, Lena Smirnova, Costanza Rovida, Marcel Leist, Thomas Hartung, Animal testing and its alternatives – the most important omics is economics, ALTEX - Alternatives to Animal Experimentation: Vol. 35 No. 3 (2018)
David Pamies, Marcel Leist, Sandra Coecke, Gerard Bowe, David G. Allen, Gerhard Gstraunthaler, Anna Bal-Price, Francesca Pistollato, Rob B. M. de Vries, Helena T. Hogberg, Thomas Hartung, Glyn Stacey, Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0), ALTEX - Alternatives to Animal Experimentation: Vol. 39 No. 1 (2022)
Thomas Hartung, Nicole Kleinstreuer, Challenges and opportunities for validation of AI-based new approach methods, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 1 (2025)
Ronit Mohapatra, Marcel Leist, Sonja von Aulock, Thomas Hartung, Guidance for Good In Vitro Reporting Standards (GIVReSt) – A draft for stakeholder discussion and background documentation, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 3 (2025)
Thomas Hartung, Lena Smirnova, Stefan Platz, Ivano Amelio, Marcel Leist, The need for epigenotoxicity testing, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 4 (2025)
Uwe Marx, Takafumi Akabane, Tommy B. Andersson, Elizabeth Baker, Mario Beilmann, Sonja Beken, Susanne Brendler-Schwaab, Murat Cirit, Rhiannon David, Eva-Maria Dehne, Isabell Durieux, Lorna Ewart, Suzanne C. Fitzpatrick, Olivier Frey, Florian Fuchs, Linda G. Griffith, Geraldine A. Hamilton, Thomas Hartung, Julia Hoeng, Helena Hogberg, David J. Hughes, Donald E. Ingber, Anita Iskandar, Toshiyuki Kanamori, Hajime Kojima, Jochen Kuehnl, Marcel Leist, Bo Li, Peter Loskill, Donna L. Mendrick, Thomas Neumann, Giorgia Pallocca, Ivan Rusyn, Lena Smirnova, Thomas Steger-Hartmann, Danilo A. Tagle, Alexander Tonevitsky, Sergej Tsyb, Martin Trapecar, Bob van de Water, Janny van den Eijnden-van Raaij, Paul Vulto, Kengo Watanabe, Armin Wolf, Xiaobing Zhou, Adrian Roth, Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development, ALTEX - Alternatives to Animal Experimentation: Vol. 37 No. 3 (2020)
Jean Knight, Costanza Rovida, Reinhard Kreiling, Cathy Zhu, Mette Knudsen, Thomas Hartung, Continuing animal tests on cosmetic ingredients for REACH in the EU, ALTEX - Alternatives to Animal Experimentation: Vol. 38 No. 4 (2021)
Lena Smirnova, Itzy E. Morales Pantoja, Thomas Hartung, Organoid intelligence (OI) – The ultimate functionality of a brain microphysiological system, ALTEX - Alternatives to Animal Experimentation: Vol. 40 No. 2 (2023)
Ivana Celardo, Michael Aschner, Randolph S. Ashton, Kelly E. Carstens, Andrea Cediel-Ulloa, Eike Cöllen, Kevin M. Crofton, Susan J. Debad, Nadine Dreser, Suzanne Fitzpatrick, Ellen Fritsche, Sebastian Gutsfeld, Barry Hardy, Thomas Hartung, Ellen Hessel, Harm Heusinkveld, Helena T. Hogberg, Jui-Hua Hsieh, Yasunari Kanda, Gavin T. Knight, Thomas Knudsen, Katharina Koch, Eliska Kuchovska, Iris Mangas, M. Sue Marty, Stephanie Melching-Kollmuss, Iris Müller, Patrick Müller, Oddvar Myhre, Martin Paparella, Emily Pitzer, Anna Bal-Price, Magdalini Sachana, Kevin Schlüppmann, Timothy J. Shafer, Jasmin Schäfer, Lena Smirnova, Tamara Tal, Yaroslav Tanaskov, Silvia Tangianu, Giuseppe Testa, Anna-Katharina Ückert, Maurice Whelan, Marcel Leist, Developmental neurotoxicity (DNT): A call for implementation of new approach methodologies for regulatory purposes: Summary of the 5th International Conference on DNT Testing, ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 2 (2025)
Uwe Marx, Sonja Beken, Zaozao Chen, Eva-Maria Dehne, Ann Doherty, Lorna Ewart, Suzanne C. Fitzpatrick, Linda G. Griffith, Zhongze Gu, Thomas Hartung, James Hickman, Donald E. Ingber, Seiichi Ishida, Jayoung Jeong, Marcel Leist, Lisa Levin, Donna L. Mendrick, Giorgia Pallocca, Stefan Platz, Marian Raschke, Lena Smirnova, Danilo A. Tagle, Martin Trapecar, Bas W. M. van Balkom, Janny van den Eijnden-van Raaij, Andries van der Meer, Adrian Roth, Biology-inspired dynamic microphysiological system approaches to revolutionize basic research, healthcare and animal welfare , ALTEX - Alternatives to Animal Experimentation: Vol. 42 No. 2 (2025)